Back to Search

PAUL WISSEL, MD

MD

Medical Oncology Physician

NPI: 1760426662Individual

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

MD044344E(PA)
Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

MD044344E(PA)

Research & Publications (10)

Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial.
PMID 19428297·Lancet Oncol·2009
4-observational
Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
PMID 19273708·J Clin Oncol·2009
3-trial
Topotecan therapy in patients with relapsed small-cell lung cancer and poor performance status.
PMID 17026814·Clin Lung Cancer·2006
8-other
Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.
PMID 16648504·J Clin Oncol·2006
3-trial
A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors.
PMID 15565444·Cancer Chemother Pharmacol·2005
3-trial
A pilot study of edrecolomab (Panorex, 17-1A antibody) and capecitabine in patients with advanced or metastatic adenocarcinoma.
PMID 12743982·Cancer Invest·2003
3-trial
Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studies.
PMID 12003197·Invest New Drugs·2002
3-trial
Androgen antagonists: Potential role in prostate cancer prevention.
PMID 11295597·Urology·2001
8-other
Antiplatelet effects of MK-852, a platelet fibrinogen receptor antagonist, in healthy volunteers.
PMID 10806603·J Clin Pharmacol·2000
3-trial
Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: a study of the EORTC Early Clinical Studies Group (ECSG).
PMID 10761757·Ann Oncol·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3400 CIVIC CENTER BOULEVARD
PHILADELPHIA, PA 19104

Location

Practice Location

3400 CIVIC CENTER BOULEVARD, PHILADELPHIA, PA
(215) 615-5858

Quick Facts

NPI
1760426662
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
10

Are you this provider?

Claim Your Profile